We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$821B
AUM Growth
+$62.3B
Cap. Flow
+$23.5B
Cap. Flow %
2.87%
Top 10 Hldgs %
16.79%
Holding
7,579
New
751
Increased
3,314
Reduced
2,056
Closed
652
Avg Time Held Equity + Options
17.5 quarters
Top 10 Avg Time Held Equity + Options
16.2 quarters
Top 20 Avg Time Held Equity + Options
12.2 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
16.2 quarters
Top 20 Avg Time Held Equity only
14.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.28%
2 Technology 17.17%
3 Healthcare 10.79%
4 Financials 9.36%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACGN
7151
DELISTED
Aceragen Inc
ACGN
$0 ﹤0.01%
10
-2
-17% -$10
2022 Q3
2 quarters
MTEM
7152
DELISTED
Molecular Templates, Inc.
MTEM
$0 ﹤0.01%
40
– –
2017 Q3
22 quarters
CPUH
7153
DELISTED
Compute Health Acquisition Corp.
CPUH
$0 ﹤0.01%
+15
New +$154
2023 Q1
0 quarters
NSL
7154
DELISTED
NUVEEN SENIOR INCM FD
NSL
– –
-4,310
Closed -$20K –
HGEN
7155
DELISTED
HUMANIGEN, INC.
HGEN
$0 ﹤0.01%
69
– –
2021 Q1
8 quarters
NMTR
7156
DELISTED
9 Meters Biopharma
NMTR
$0 ﹤0.01%
7
– –
2021 Q2
7 quarters
GGAA
7157
DELISTED
Genesis Growth Tech Acquisition Corp. Class A Ordinary Shares
GGAA
– –
-74,000
Closed -$765K –
VBOC
7158
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
– –
-2,000
Closed -$20K –
TESS
7159
DELISTED
Tessco Technologies Inc
TESS
$0 ﹤0.01%
7
– –
2019 Q2
15 quarters
FMIV
7160
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
– –
-19,586
Closed -$197K –
BICK
7161
DELISTED
First Trust BICK Index Fund
BICK
– –
-609
Closed -$15K –
HWKZ
7162
DELISTED
Hawks Acquisition Corp
HWKZ
– –
-2,000
Closed -$20K –
ISEE
7163
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-106,300
Closed -$2.28M –
STCN
7164
DELISTED
Steel Connect, Inc. Common Stock
STCN
$0 ﹤0.01%
1
– –
2021 Q2
7 quarters
ONCR
7165
DELISTED
Oncorus, Inc.
ONCR
$0 ﹤0.01%
353
– –
2020 Q4
9 quarters
DCP
7166
CALL
DELISTED
DCP Midstream, LP
DCP
– –
-260,900
Closed -$10.1M –
DCP
7167
PUT
DELISTED
DCP Midstream, LP
DCP
– –
-93,100
Closed -$3.61M –
CS
7168
PUT
DELISTED
Credit Suisse Group
CS
– –
-334,600
Closed -$1.02M –
ACOR
7169
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
1
– –
2021 Q1
8 quarters
BLCM
7170
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
1
– –
2022 Q4
1 quarter
PNTM
7171
DELISTED
Pontem Corporation
PNTM
$0 ﹤0.01%
+12
New +$123
2023 Q1
0 quarters
LABP
7172
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$0 ﹤0.01%
61
– –
2021 Q1
8 quarters
SEAC
7173
DELISTED
Seachange International Inc
SEAC
$0 ﹤0.01%
6
– –
2022 Q3
2 quarters
VNTR
7174
DELISTED
Venator Materials PLC
VNTR
$0 ﹤0.01%
9
-1,568
-99% -$858
2020 Q1
12 quarters
EVOJ
7175
DELISTED
Evo Acquisition Corp. Class A Common Stock
EVOJ
– –
-305,458
Closed -$3.13M –

Similar funds

JP Morgan Chase's Q1 2023 Portfolio in Review

As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
  • JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
  • JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
  • JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
  • JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.